Showing 1 - 7 results of 7 for search 'Ravi K. Anchoori', query time: 0.03s Refine Results
  1. 1
    Early and consistent overexpression of ADRM1 in ovarian high-grade serous carcinoma

    Early and consistent overexpression of ADRM1 in ovarian high-grade serous carcinoma by Rosie T. Jiang, Anna Yemelyanova, Deyin Xing, Ravi K. Anchoori, Jun Hamazaki, Shigeo Murata, Jeffrey D. Seidman, Tian-Li Wang, Richard B. S. Roden

    Published 2017-08-01
    Get full text
    Article
  2. 2
    Stressing the ubiquitin-proteasome system without 20S proteolytic inhibition selectively kills cervical cancer cells.

    Stressing the ubiquitin-proteasome system without 20S proteolytic inhibition selectively kills cervical cancer cells. by Ravi K Anchoori, Saeed R Khan, Thanasak Sueblinvong, Alicia Felthauser, Yoshie Iizuka, Riccardo Gavioli, Federica Destro, Rachel Isaksson Vogel, Shiwen Peng, Richard B S Roden, Martina Bazzaro

    Published 2011-01-01
    Get full text
    Article
  3. 3
    Bis-benzylidine Piperidone RA190 treatment of hepatocellular carcinoma via binding RPN13 and inhibiting NF-κB signaling

    Bis-benzylidine Piperidone RA190 treatment of hepatocellular carcinoma via binding RPN13 and inhibiting NF-κB signaling by Ruey-Shyang Soong, Ravi K. Anchoori, Richard B. S. Roden, Rou-Ling Cho, Yi-Chan Chen, Sheng-Chieh Tseng, Yun-Li Huang, Po-Cheng Liao, Yu-Chiau Shyu

    Published 2020-05-01
    Get full text
    Article
  4. 4
    Development and anticancer properties of Up284, a spirocyclic candidate ADRM1/RPN13 inhibitor.

    Development and anticancer properties of Up284, a spirocyclic candidate ADRM1/RPN13 inhibitor. by Ravi K Anchoori, Vidyasagar Anchoori, Brandon Lam, Ssu-Hsueh Tseng, Samarjit Das, Fernanda Carrizo Velasquez, Balasubramanyam Karanam, Deepika Poddatoori, Ramesh Patnam, Michelle A Rudek, Yung-Nien Chang, Richard B S Roden

    Published 2023-01-01
    Get full text
    Article
  5. 5
    Structure-function analyses of candidate small molecule RPN13 inhibitors with antitumor properties.

    Structure-function analyses of candidate small molecule RPN13 inhibitors with antitumor properties. by Ravi K Anchoori, Marietta Tan, Ssu-Hsueh Tseng, Shiwen Peng, Ruey-Shyang Soong, Aliyah Algethami, Palmer Foran, Samarjit Das, Chenguang Wang, Tian-Li Wang, Hong Liang, Chien-Fu Hung, Richard B S Roden

    Published 2020-01-01
    Get full text
    Article
  6. 6
    Covalent Rpn13-Binding Inhibitors for the Treatment of Ovarian Cancer

    Covalent Rpn13-Binding Inhibitors for the Treatment of Ovarian Cancer by Ravi K. Anchoori, Rosie Jiang, Shiwen Peng, Ruey-shyang Soong, Aliyah Algethami, Michelle A. Rudek, Nicole Anders, Chien-Fu Hung, Xiang Chen, Xiuxiu Lu, Olumide Kayode, Marzena Dyba, Kylie J. Walters, Richard B. S. Roden

    Published 2018-09-01
    Get full text
    Article
  7. 7
    Chirality and asymmetry increase the potency of candidate ADRM1/RPN13 inhibitors.

    Chirality and asymmetry increase the potency of candidate ADRM1/RPN13 inhibitors. by Ravi K Anchoori, Logan George, Ssu-Hsueh Tseng, Brandon Lam, Srinidhi Polkampally, Anjali D Amiano, Palmer Foran, Hannah Tsingine, Harideep Samanapally, Fernanda Carrizo Velasquez, Samarjit Das, Deyin Xing, Ahmad Bin Salam, Balasubramanyam Karanam, Chien-Fu Hung, Richard B S Roden

    Published 2021-01-01
    Get full text
    Article

Search Tools: